Navigation Links
September is Leukemia, Lymphoma and Myeloma Awareness Month
Date:9/12/2007

Tremendous advances have been made to treat blood cancer but the battle is

far from won

WHITE PLAINS, N.Y., Sept. 12 /PRNewswire/ -- Remarkable progress has been made in treating patients with blood cancers. Sixty years ago there were few effective treatments for children or adults with blood cancer and the rate of survival was very low. Today, about 75 percent of children with acute leukemia and nearly 80 percent of children and adults with Hodgkin lymphoma are cured. Improved therapies and stem cell transplantation have dramatically improved survival rates for most blood cancers, and even patients with diseases resistant to treatment, such as myeloma, are benefiting from new drugs that are increasing the rate and duration of remissions.

Yet, more than three quarters of a million people in the United States currently have some form of blood cancer. Every ten minutes someone dies from a blood cancer and an estimated 52,310 will die from one this year.

The Leukemia & Lymphoma Society is a beacon of help and guidance to those touched by blood cancer and each September the Society observes Leukemia, Lymphoma and Myeloma Awareness Month, to shed light on these diseases and let the public know that there are resources available for blood cancer patients and their families.

"Awareness Month is an opportunity to increase the public's understanding of blood cancers and encourage people to support the funding of research to find cures and education programs to help patients have the best possible outcomes throughout their cancer experience," said Dwayne Howell, the Society's President and CEO.

Since its inception in 1949, the Society has invested more than $550 million in research to find cures and better therapies, and funded $64.9 million in 2007 alone. The Society supports investigators' efforts to find new molecular targets for treatment and potential immunotherapies, and helps them translate their labo
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
4. Fractionated Radioimmunotherapy With (90)Y-epratuzumab in Non-Hodgkins Lymphoma Appears Safe and Active in a Phase I/II Study
5. Favrille Announces Data From Phase 2 Clinical Trial of FavId for Indolent B-Cell Non-Hodgkins Lymphoma in Europe
6. Gloucester Pharmaceuticals Reports Positive Interim Phase II Data on Romidepsin for T-Cell Lymphomas at the 2007 American Society of Clinical Oncology Annual Meeting
7. Nuvelo Announces Publication of Preclinical Study Results Demonstrating the Potential of NTB-A as a New Target for Leukemia and Lymphomas
8. Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
9. Phase 2 Clinical Results of Ganite Plus Standard Therapy in Patients with Relapsed/Refractory Lymphoma Presented at ASCO
10. Phase 2 Clinical Results of Ganite Plus Standard Therapy in Patients with Relapsed/Refractory Lymphoma Presented at ASCO
11. MabThera Significantly Extends Survival And Cures More Patients With Aggressive Lymphoma Than Chemotherapy Alone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... Pharmaceutical Care Management Association (PCMA) President and ... that could reduce prescription fraud and abuse in Medicare ... Opioid Abuse: Fighting Back on Many Fronts ," sponsored ... The briefing featured several government and industry ... fraud. The Centers for Disease Control and Prevention has ...
(Date:9/29/2014)... YORK , Sept. 29, 2014 ... GlobalData,s new report, "EU5 Sigmoidoscopes Market Outlook ... EU5 Sigmoidoscopes market. The report provides value, in ... average prices (in US dollars) within market segments ... Non-Video Sigmoidoscopes and Flexible Non-Video (Fibre) Sigmoidoscopes). ...
(Date:9/29/2014)... SAN DIEGO , 29 de septiembre ... aquí en adelante, Daiichi Sankyo) (TSE: 4568) y Ambit ... conjunta hoy que han llegado a un acuerdo de ... todas las acciones ordinarias de Ambit Biosciences a un ... medio de una oferta de licitación seguida de una ...
Breaking Medicine Technology:PCMA: How Congress Can Fight Prescription Drug Fraud and Abuse 2EU5 Sigmoidoscopes Market Outlook to 2020 2EU5 Sigmoidoscopes Market Outlook to 2020 3Daiichi Sankyo adquiere Ambit Biosciences 2Daiichi Sankyo adquiere Ambit Biosciences 3Daiichi Sankyo adquiere Ambit Biosciences 4Daiichi Sankyo adquiere Ambit Biosciences 5Daiichi Sankyo adquiere Ambit Biosciences 6Daiichi Sankyo adquiere Ambit Biosciences 7Daiichi Sankyo adquiere Ambit Biosciences 8
... 11, 2011 Isis Pharmaceuticals, Inc. (NASDAQ: ... second development candidate, ISIS-AATRx, in its collaboration with GlaxoSmithKline ... payment from GSK for the selection of ISIS-AATRx.  ISIS-AATRx ... caused by alpha-1 antitrypsin deficiency, or AATD, by inhibiting ...
... 11, 2011 Reportlinker.com announces that ... available in its catalogue: ... http://www.reportlinker.com/p0358494/North-American-External-Defibrillator-Market.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices ... state of the North American external ...
Cached Medicine Technology:Isis Selects Development Candidate, Isis-AATRx, to Treat AATD-Associated Liver Disease 2Isis Selects Development Candidate, Isis-AATRx, to Treat AATD-Associated Liver Disease 3Isis Selects Development Candidate, Isis-AATRx, to Treat AATD-Associated Liver Disease 4North American External Defibrillator Market 2North American External Defibrillator Market 3North American External Defibrillator Market 4North American External Defibrillator Market 5North American External Defibrillator Market 6North American External Defibrillator Market 7
(Date:9/29/2014)... 30, 2014 NAPW honors ... Professional Woman of the Year. Dr. Mondloch is recognized ... preventative medicine As the largest, most-recognized networking organization of ... and profession, the National Association of Professional Women is ... and nearly 300 Local Chapters. , “Initially my goal ...
(Date:9/29/2014)... NAPW honors Natalie W. ... Private Pediatrics of Palm Beach as a 2014 ... leadership in pediatrics and family care with this prestigious ... the country, spanning virtually every industry and profession, the ... vibrant networking community with over 600,000 members and nearly ...
(Date:9/29/2014)... 30, 2014 Top10BestSEOHosting.com is a ... about hosting products. It is headed by a ... The site offers research-based information and factual studies ... in the current market. , Top10BestSEOHosting.com has ... that GoDaddy ( http://www.top10bestseohosting.com/go/GoDaddy.com/ ) and Bluehost are ...
(Date:9/29/2014)... Every autumn, as high school and ... running season takes off! Athletes typically train throughout the ... season. Zensah®, the leading compression apparel company, makes the ... socks for cross country running. , The ... delayed onset muscle soreness (DOMS) throughout training in addition ...
(Date:9/29/2014)... 29, 2014 International Alliance for ... provide students with a certification program that gives ... enhance their own lives, and the lives of ... benefits the community at large, through innovative certification ... the professional practice of fitness, wellness, nutrition, health, ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Victoria J. Mondloch, M.D., Family Medicine and Women's Health, a 2014 Professional Woman of the Year 2Health News:National Association of Professional Women Announces Dr. Natalie W. Geary, Owner / President of Private Pediatrics of Palm Beach, a 2014 Professional Woman of the Year 2Health News:Top10BestSEOHosting.com: New Reviews for Linux Web Hosting Suppliers Available Online 2Health News:Muscle Support and Style With New Compression Leg Sleeves For Cross Country Runners 2Health News:Narconon Louisiana New Life Retreat Announces Stephen Mogavero Now Certified as a Personal Trainer 2
... , WEDNESDAY, June 29 (HealthDay News) -- Variations of a ... at happy faces, a finding that may help improve understanding ... at people,s faces helps us read their emotions, but some ... especially true of people with autism. The ...
... (HealthDay News) -- A new study reveals that 90 percent ... substances started smoking, drinking or using drugs before they were ... of Americans who began using any addictive substance before age ... started using an addictive substance when they were 21 or ...
... The genome of the most common form of ovarian cancer ... surprisingly frequent structural changes in the genome itself, said members ... Baylor College of Medicine ( www.bcm.edu ) Human Genome ... than 300 such tumors. The study was the first to ...
... Aviv Parkinson,s Disease, brought to public awareness by ... difficult to diagnose. It,s also difficult to accurately estimate ... statistics come from small-scale studies, usually based on information ... exist to track how many people have the disease. ...
... Americans experience chronic pain, a condition that costs the nation ... report from the Institute of Medicine. Much of this ... committee that wrote the report. The committee ... to create a cultural transformation in how the nation understands ...
... , WEDNESDAY, June 29 (HealthDay News) -- Giving flu shots ... Flu vaccination is recommended for anyone older than 6 months ... than 6 months, who have the highest rates of flu ... analyzed data from about 1,500 babies who were hospitalized for ...
Cached Medicine News:Health News:Addiction Starts Early in American Society, Report Finds 2Health News:Addiction Starts Early in American Society, Report Finds 3Health News:Sequence of ovarian genome identifies predominant gene mutations, points to possible treatment 2Health News:Sequence of ovarian genome identifies predominant gene mutations, points to possible treatment 3Health News:Sequence of ovarian genome identifies predominant gene mutations, points to possible treatment 4Health News:Getting an accurate read on Parkinson's 2Health News:Getting an accurate read on Parkinson's 3Health News:IOM report calls for cultural transformation of attitudes toward pain and its prevention and management 2Health News:IOM report calls for cultural transformation of attitudes toward pain and its prevention and management 3
Micro-retractor arm 12"....
... designed for the retraction of nerves, vessels, tissue, ... Equalizes brain retraction pressure. Decreases shear injury to ... conjunction with the Budde Halo Retractor. Range of ... 2 mm and 4 mm wide. Quick change ...
Telescopic Diamond-Dissectors for delicate sharp tissue preparation. Total/working lengths 220/240 mm with protective sleeve....
Cone Ring Curettes, length 9" (229 mm), ring diameter (I.D.) 5/16" (8 mm)....
Medicine Products: